The Canadian LP is entering medical markets via trials and individualized patient imports in both the U.S. and the UK as it also gears up for the recreational market in Canada.
Health Canada, the Canadian military, sports organizations and provincial governments continue to issue (and revise) guidelines as the October market start looms.
As the October 17 deadline looms, what is the state of provincial reform in Canada and who stands to have the most influence in local markets?
GW Pharmaceuticals’ eye-watering price tag for its new CBD drug might fly (temporarily) in the U.S., but in Europe, competition is being encouraged.
A step-by-step guide to evaluating potential suppliers of packaging, active ingredients and excipients for cannabis-infused products.
Employee training at the retail level can dramatically improve sales and help inform consumers and patients.
This article will help businesses better understand the distillation chemistry used to produce a cannabis distillate product.
Europe’s cannabis reforms and market opening might be all the rage right now in the mainstream global industry, but what about the jolly green cannabis giant, China?
It is hardly an “October Surprise” that global markets are starting to align on timing issues – but what does this odd situation herald for the burgeoning international industry?
After outlining the risks to address in quality plans earlier in the series, Dr. Askew shows how your brand can suffer in the court of public opinion.
